Document is current
Any future updates will be listed below
-
Authors
Park, Juyeon
Shin, Su-Jin https://orcid.org/0000-0001-9114-8438
Kim, Geon
Cho, Hyungjoo
Ryu, Dongmin https://orcid.org/0000-0003-3600-281X
Ahn, Daewoong
Heo, Ji Eun
Clemenceau, Jean R. https://orcid.org/0000-0002-6222-6457
Barnfather, Isabel
Kim, Minji https://orcid.org/0009-0009-6787-0354
Jang, Inyeop
Sung, Ji-Youn https://orcid.org/0000-0002-6607-2117
Park, Jeong Hwan https://orcid.org/0000-0003-4522-9928
Min, Hyun-seok https://orcid.org/0000-0002-7435-7884
Lee, Kwang Suk
Cho, Nam Hoon
Hwang, Tae Hyun https://orcid.org/0000-0002-6668-7269
Park, YongKeun https://orcid.org/0000-0003-0528-6661
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 6 May 2025
First Online: 22 May 2025
Competing interests
: D.R., D.A., H.C., H.-S.M. and Y.K.P. have financial interests in Tomocube, a company that commercializes holotomography instruments. T.H.H. is a scientific co-founder of Kure.ai Therapeutics and its subsidiary, Kure.S. He holds no official roles in the companies and receives no salary or consulting fees. The companies did not influence the design, execution, or interpretation of this study. All other authors declare no competing interests.
